Compare WAFD & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WAFD | INSP |
|---|---|---|
| Founded | 1917 | 2007 |
| Country | United States | United States |
| Employees | 2037 | 1333 |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 1.6B |
| IPO Year | N/A | 2018 |
| Metric | WAFD | INSP |
|---|---|---|
| Price | $35.60 | $54.83 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 16 |
| Target Price | $35.00 | ★ $94.00 |
| AVG Volume (30 Days) | 646.6K | ★ 854.2K |
| Earning Date | 04-16-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.08% | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | N/A | ★ 4.89 |
| Revenue | N/A | ★ $82,050,000.00 |
| Revenue This Year | N/A | $8.02 |
| Revenue Next Year | $4.15 | $8.11 |
| P/E Ratio | $11.49 | ★ $10.90 |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $26.31 | $48.30 |
| 52 Week High | $36.02 | $163.35 |
| Indicator | WAFD | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 69.52 | 47.80 |
| Support Level | $31.67 | $52.37 |
| Resistance Level | $36.02 | $60.15 |
| Average True Range (ATR) | 0.79 | 2.58 |
| MACD | 0.14 | 0.18 |
| Stochastic Oscillator | 89.18 | 45.17 |
WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.